SARL Kinomé – Trademark Portfolio

Entity Type: 99

SARL Kinomé holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 5 Nice Classification classes. The owner is based in Montreuil sous Bois.

8 rue de Valmy

Montreuil sous Bois 93100 , FR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SARL Kinomé's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does SARL Kinomé have?

SARL Kinomé has 2 U.S. trademarks filed with the USPTO.

What trademark classes does SARL Kinomé file in?

SARL Kinomé files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 31 (Natural Agricultural Products), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.

What is SARL Kinomé's trademark registration success rate?

SARL Kinomé has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.